ZHEJIANG SHOUXIANGU PHARMACEUTICAL revenue breakdown overview

ZHEJIANG SHOUXIANGU PHARMACEUTICAL revenue for the last year amounted to 784.00 M CNY, the most of which — 243.94 M CNY — came from its highest performing source at the moment, Broken Ganoderma Lucidum Spore Powder, the year earlier bringing 259.99 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought ZHEJIANG SHOUXIANGU PHARMACEUTICAL 784.35 M CNY, and the year before that — 829.07 M CNY.